Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2022

View Archived Issues

CRV-431 is a possible treatment approach for ALD

Thrombospondin-1 found to be involved in pathogenesis of acute-on-chronic liver failure

Albireo patents SLC10A1 and/or SLC10A2 inhibitors

Qurient Therapeutics discloses new CDK7 inhibitors

Tuojie Biotech identifies new P2X3 antagonists

Stingray Therapeutics synthesizes ENPP1 inhibitors

Roche discovers new EGFR mutant inhibitors for NSCLC

KLB as a novel druggable target for the prevention of NAFLD

CSF1R inhibition could delay muscular dystrophy progression

Extended funding supports Errium's development of therapeutics for chronic autoimmune diseases

Ildong licenses Twist VHH antibody libraries for antibody discovery in immuno-oncology

China NMPA approves IND for Henlius' anti-TIGIT Fc fusion protein HLX-53

Anti-alpha-1-antitrypsin BMN-349 reverses liver disease in a preclinical model

Sutro Biopharma generates hemiasterlin/TLR agonist dual-conjugate anti-FolR-alpha ADCs

ENT1 inhibitor reverses sporadic Alzheimer's disease in mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...